InvestorsObserver
×
News Home

Is Kaleido Biosciences Inc (KLDO) Stock a Good Value Monday?

Monday, March 29, 2021 11:45 AM | InvestorsObserver Analysts

Mentioned in this article

Is Kaleido Biosciences Inc (KLDO) Stock a Good Value Monday?

The 49 rating InvestorsObserver gives to Kaleido Biosciences Inc (KLDO) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 79 percent of stocks in the Healthcare sector, KLDO’s 49 overall rating means the stock scores better than 49 of all stocks.

Overall Score - 49
KLDO has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on KLDO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Kaleido Biosciences Inc Stock Today?

Kaleido Biosciences Inc (KLDO) stock is trading at $7.22 as of 11:40 AM on Monday, Mar 29, a decline of -$0.45, or -5.87% from the previous closing price of $7.67. The stock has traded between $7.10 and $8.14 so far today. Volume today is below average. So far 152,612 shares have traded compared to average volume of 255,286 shares.

Click Here to get the full Stock Score Report on Kaleido Biosciences Inc (KLDO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App